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HSPB1 facilitates ERK-mediated phosphorylation and
degradation of BIM to attenuate endoplasmic reticulum
stress-induced apoptosis
Donna Kennedy1,8, Katarzyna Mnich1,8, Deepu Oommen1, Reka Chakravarthy1, Leonardo Almeida-Souza2,3, Michiel Krols2,3,
Svetlana Saveljeva1, Karen Doyle4, Sanjeev Gupta5, Vincent Timmerman2,3, Sophie Janssens6,7, Adrienne M Gorman1 and
Afshin Samali*,1
BIM, a pro-apoptotic BH3-only protein, is a key regulator of the intrinsic (or mitochondrial) apoptosis pathway. Here, we show that
BIM induction by endoplasmic reticulum (ER) stress is suppressed in rat PC12 cells overexpressing heat shock protein B1 (HSPB1
or HSP27) and that this is due to enhanced proteasomal degradation of BIM. HSPB1 and BIM form a complex that
immunoprecipitates with p-ERK1/2. We found that HSPB1-mediated proteasomal degradation of BIM is dependent on MEK-ERK
signaling. Other studies have shown that several missense mutations in HSPB1 cause the peripheral neuropathy, Charcot-Marie-
Tooth (CMT) disease, which is associated with nerve degeneration. Here we show that cells overexpressing CMT-related HSPB1
mutants exhibited increased susceptibility to ER stress-induced cell death and high levels of BIM. These findings identify a novel
function for HSPB1 as a negative regulator of BIM protein stability leading to protection against ER stress-induced apoptosis, a
function that is absent in CMT-associated HSPB1 mutants.
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B-cell lymphoma-2 (BCL-2) family proteins are key regulators
of the intrinsic apoptosis pathway. Activation of the multi-
domain pro-apoptotic members of the family, BCL-2-
associated X protein (BAX) and BCL-2-antagonist/killer
(BAK), causes mitochondrial outer membrane permeabiliza-
tion (MOMP) and the release of pro-apoptotic factors such as
cytochrome c into the cytosol.1 The outcome of MOMP is cell
death due to caspase activation. BAX/BAK activation occurs
either directly or indirectly by BCL-2 homology domain (BH) 3-
containing proteins (BH3-only proteins),2,3 whose expression
is induced in response to stress stimuli.4–6
BCL-2 interacting mediator of cell death (BIM) is a BH3-only
protein that is induced by a range of cellular stresses,
ultimately causing cell death.4,5,7 Thus, BIM levels in cells
are under strict regulation to avoid unwanted apoptosis. The
regulation of BIM levels is multifaceted. It is transcriptionally
induced by transcription factors such as FOXO3 and CHOP.7,8
Bim mRNA is also post-transcriptionally regulated by micro-
RNAs such as miR17-92, which bind to the 3′UTR causing
degradation ofBimmRNA and/or preventing its translation.9,10
Conversely, certain stresses such as endoplasmic reticulum
(ER) stress can repress microRNAs, indirectly increasing BIM
levels.11 BIM can be phosphorylated by members of mitogen
activated protein kinase family; Extracellular signal-regulated
kinase 1/2 (ERK1/2)-mediated phosphorylation stimulates
BIM degradation via the proteasome,12,13 whereas
phosphorylation mediated by c-Jun N-terminal kinase (JNK)
increases BIM pro-apoptotic activity.14 Recently, a deubiqui-
tinase was identified that counteracts ERK-dependent BIM
ubiquitination, thus stabilizing BIM.15
Heat shock preconditioning protects cells from stresses that
would ordinarily be toxic.16,17 These effects are mediated by
inducible heat shock proteins (HSPs), including HSPB1,
which is a potent inhibitor of apoptosis signaling by diverse
cellular stressors.18–22 HSPB1 can indirectly inhibit BAX
activation/oligomerization and MOMP induction to reduce
cytochrome c release from the mitochondria.20,23 Mutations in
HSPB1 are associated with progressive degeneration of
peripheral nerves in the inherited peripheral neuropathies
Charcot-Marie-Tooth disease type 2F (CMT2F) and distal
hereditary motor neuropathy (dHMN).24 There is strong
evidence that cellular stress such as ER stress features in
certain forms of CMT25 highlighting the importance of under-
standing how HSPB1 regulates this.
Here we show that overexpression of HSPB1 confers
protection against apoptosis triggered by ER stress by
enhancing the proteasomal degradation of BIM. This effect
was dependent on ERK1/2-mediated phosphorylation of BIM.
Furthermore, we show that HSPB1 and BIM form a complex
with phospho-ERK1/2 that mediates BIM degradation. In
contrast to the wild-type HSPB1 protein, HSPB1 variants with
CMT-related mutations (S135F, R127W, R136W and T151I)
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Figure 1 HSPB1 overexpression attenuates ER stress-induced apoptosis. (a) Protein extracts of wild-type (WT), empty vector (EV) and HSPB1 PC12 were immunoblotted
for HSPB1 and ACTIN (n= 3). (b) EV and HSPB1 PC12 cells were treated with the indicated concentration of TG. Cell viability was assessed by MTT (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) assay 24 h and 48 h after treatment (n= 4). (c,d) EV and HSPB1 PC12 were treated with vehicle or with 0.25 μM TG for 48 h.
Representative bright-field microscopy images of hematoxylin and eosin stained cells are presented (n= 3) (c). The percentage of cell death was determined by flow cytometry-
based measurement of Annexin V positivity (n= 8) (d). (e–g) EV and HSPB1 PC12 cells were treated with a vehicle or 0.25 μM TG for the indicated time. Lysates were
immunoblotted for full and cleaved caspase-9 and -3. ACTIN was used as loading control (n= 3) (e). DEVDase activity was measured in whole lysates from cells treated with
0.25 μM TG for the indicated time (n= 8) (f). Release of cytochrome c into cytosol was monitored by immunoblotting. ACTIN was used as a loading control (n= 3) (g). (h) Loss of
mitochondrial membrane potential (ΔΨm) was determined by flow cytometry-based measurement of the percentage of TMRE positive EVand HSPB1 cells after treatment with a
vehicle or 0.25 μM TG for 48 h (n= 3). Data are representative or average±S.E.M. of indicated number of independent biological replicates. Significance was determined using
two-way ANOVA followed by Bonferroni’s post hoc analysis, with Po0.05 being considered significant and annotated by *Po0.05, **Po0.001, ***Po0.0001
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failed to protect against ER stress and were associated with a
pronounced increase in BIM levels. Taken together, our data
provide another facet to our understanding of how HSPB1
protects upstream of MOMP during apoptosis and show that
expression of HSPB1 with CMT-related mutations exacer-
bates ER stress in cells.
Results
HSPB1 overexpression attenuates ER stress-induced
intrinsic apoptosis. We showed previously that heat shock
preconditioning protected cells from ER stress-induced
apoptosis.17 To investigate the role of HSPB1 in that
protection, we compared the effect of the two classical ER
stress inducers, thapsigargin (TG) and tunicamycin (TM), on
PC12 cells stably expressing empty vector (EV) pcDNA3.1 or
a vector carrying the full-length human HSPB1 cDNA
sequence (Figure 1a). Treatment of EV cells with increasing
concentrations of TG resulted in a significant reduction in cell
viability that was ameliorated in cells expressing HSPB1
(Figure 1b). TG-treated EV cells displayed morphological
characteristics of apoptosis including cell shrinkage, chro-
matin condensation and plasma membrane blebbing, fea-
tures which were attenuated in cells overexpressing HSPB1
Figure 2 HSPB1 overexpression protects in a BIM-dependent manner. (a, b) Cells expressing EV or HSPB1, were treated with a vehicle or 0.25 μM TG for up to 48 h.
Lysates were immunoblotted for expression of BIM and ACTIN (n= 3) (a). Densitometric and statistical analysis of BIM expression was carried out, and normalized to loading
control (b). (c–e) EV and HSPB1 cells were transfected with Bim siRNA or a non-targeting control siRNA (ctrl). The percentage of Annexin V positive cell was analyzed in cells
treated with TG for 48 h (n= 4) (c). DEVDase activity was measured in lysates from cells treated with TG for 36 h (n= 4) (d). Protein lysates from cells treated with TG for 48 h
were immunoblotted for BIM and ACTIN (n= 2) (e). (f) Wild-type PC12 cells were transfected with rat HspB1 siRNA or a non-targeting control siRNA (ctrl) and treated with a
vehicle or 0.25 μM TG 24 h later for up to 48 h. Lysates were immunoblotted for HSPB1, BIM, cleaved caspase-3 and HSPA1. ACTIN was used as a loading control (n= 2). Data
are representative or the average±S.E.M. of indicated number of independent biological replicates. Significance was determined using Two-way ANOVA followed by Bonferroni’s
post hoc analysis, with Po0.05 being considered significant and annotated by *Po0.05, ***Po0.0001, ****Po0.00001, ns (not significant)
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(Figure 1c). We confirmed that HSPB1 protects against
apoptosis by measuring Annexin V staining (Figure 1d),
monitoring pro-caspase-9 and pro-caspase-3 processing
(Figure 1e), and caspase-3/-7 activity (DEVDase assay)
(Figure 1f). Similarly, caspase processing and activation,
induced by TM, were also attenuated in presence of HSPB1
(Supplementary Figure 1a and b). ER stress-induced death is
primarily via the intrinsic apoptosis pathway.26 We found that
HSPB1 reduced the loss of Δψm and cytochrome c release
into the cytosol of TG-treated cells compared to EV counter-
parts (Figures 1g and h). Collectively, these results indicate
that HSPB1 acts upstream of MOMP to attenuate ER stress-
induced apoptosis.
We confirmed UPR activation by TG in the presence and
absence of HSPB1 by induction of HSPA5 (also called
GRP78), CHOP upregulation, PERK activation (determined
by PERK upshift) and eIF2α phosphorylation (Supplementary
Figure 2a and b).
HSPB1 downregulates BIM to attenuate ER stress-
induced apoptosis. Given that heat shock preconditioning
protects against ER stress-induced apoptosis in PC12 cells
through HSPA1-independent downregulation of BIM,17 we
examined the role of HSPB1 to regulate ER stress-induced
BIM. Following ER stress there was a time-dependent
increase in BIM expression in EV cells, which was
significantly reduced in HSPB1 cells (Figures 2a and b;
Supplementary Figure 1c and d). These findings were also
confirmed using cells transiently overexpressing HSPB1,
demonstrating that the effect of HSPB1 on BIM is not due to
selection of stably transfected cells for deregulated
responses to stress (Supplementary Figure 1e). The
significance of BIM downregulation by HSPB1 for protection
against ER stress was confirmed in EV and HSPB1-
expressing cells transfected with Bim siRNA and subjected
to ER stress (Figures 2c–e).
Next, we knocked down endogenous Hspb1 in wild-type
PC12 cells using siRNA. As expected, Hspb1 knockdown
resulted in BIM accumulation in cells treated with TG
compared with control siRNA-transfected counterparts,
confirming that HSPB1 is necessary for downregulation of
BIM. However, there was no impact on caspase-3 processing
Figure 3 Cells expressing mutants of HSPB1 fail to attenuate ER stress-induced apoptosis and express high levels of BIM. (a) Protein lysates from PC12 cells expressing
empty vector (EV), wild-type HSPB1, mutant HSPB1 S135F, R127W, R136W and T151I were immunoblotted for HSPB1 and ACTIN (n= 2). (b–d) EV, wild-type HSPB1, S135F,
R127W, R136Wand T151I PC12 cells were treated with 0.25 μM TG for 24 and 48 h. The percentage of apoptotic cells was determined by flow cytometry-based measurement of
Annexin V positivity (n= 4) (b). Loss of mitochondrial membrane potential (ΔΨm) was determined by flow cytometry-based measurement of the percentage of TMRE positive EV
and HSPB1 cells after treatment with a vehicle or 0.25 μM TG for 24 and 48 h (n= 3) (c). Lysates were immunoblotted for BIM, cleaved caspase-3 and ACTIN (n= 3) (d). Data
are representative or average± S.E.M. of indicated number of independent biological replicates. Significance was determined using Two-way ANOVA followed by Bonferroni’s
post hoc analysis, with Po0.05 being considered significant and annotated by *Po0.05, **Po0.001
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(Figure 2f). We previously demonstrated that HSPA1 over-
expression inhibits ER stress-induced apoptosis in PC12 cells
independent of BIM downregulation.17,27 Given that HSPB1 is
induced by ER stress, we checked if HSPA1 is also elevated
and found that TG-induced expression of both HSPB1 and
HSPA1 (Figure 2f and Supplementary Figure 2c–e). That
indicates that induction of HSPs is a general response of
PC12 cells to ER stress. We also observed a slight increase in
HSPA1 protein levels upon depletion of HSPB1, suggesting a
compensatory upregulation of other HSPs in the absence of
Figure 4 The reduced expression of BIM in HSPB1 cells undergoing ER stress is due to proteasomal degradation. (a) RT-qPCR analysis of BimmRNA expression in EVand
HSPB1 cell treated with 0.25 μM TG for up to 36 h. Values were normalized to Gapdh. Data are average± S.E.M. of three independent biological repeats. (b) PC12 cells were
transfected with Bim 3'UTR reporter or control plasmid and treated with TG for 24 h. Values were normalized to Firefly luciferase activity and expression relative to control plasmid
is shown. Data are average±S.E.M. of three independent biological repeats. (c–e) PC12 cells were treated with a vehicle or with TG for 18 h, followed by 10 μM cycloheximide
(CHX) treatment for up to 3 h. Cell lysates were immunoblotted for BIM and ACTIN (n= 3) (c). Densitometric analysis of BIM expression in the absence (d) and presence of TG
(e) was normalized to ACTIN and expressed relative to proper control. Exponential trend lines were fitted through the data points in Word Excel, and the equations were used to
calculate half-lives. Values are the average±S.D. of three independent biological replicates. (f) HSPB1 PC12 cells were pre-treated with TG for 18 h to induce BIM, followed by
treatment with 10 μM CHX and 20 μM MG132 for the indicated time. Lysates were immunoblotted for BIM. ACTIN was used as a loading control (n= 3). Data are representative
of indicated number of independent biological replicates. Significance was determined using two-way ANOVA followed by Bonferroni’s post hoc analysis, with Po0.05 being
considered significant and annotated by *Po0.05. ns (not significant)
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HSPB1 (Figure 2f), which could further contribute to regulation
of caspase-3 processing downstream of BIM.28,29
Cells expressing HSPB1 with CMT-associated mutations
are not protected and express high levels of BIM. Muta-
tions in HSPB1 are associated with disease progression and
degeneration of peripheral neurons in CMT neuropathy, but
the mechanism remains obscure. We therefore examined the
ability of CMT-associated HSPB1 mutants to protect against
ER stress-induced apoptosis and to downregulate BIM. We
generated PC12 cell lines stably expressing EV plasmid,
wild-type HSPB1 (WT) or HSPB1 with CMT-related point
mutations (S135F, R127W, R136W or T151I) (Figure 3a).
These HSPB1 mutants were chosen because they are
located in the α-crystallin domain of HSPB1, previously
identified as a ‘hot-spot’ in relation to small HSP (sHSP)-
associated neuropathies,30 and reported to cause CMT.31
Although cells overexpressing WT HSPB1 were significantly
resistant to ER stress, functional analysis revealed that all
mutants failed to protect cells from TG-induced apoptosis
(Figures 3b–d), exhibiting no difference in Annexin V staining
(Figure 3b), Δψm (Figure 3c) or caspase-3 cleavage
(Figure 3d) between TG-treated cells overexpressing HSPB1
mutants and EV controls. Interestingly, whereas WT HSPB1
reduced levels of BIM in stressed cells, the HSPB1 mutants
did not prevent BIM accumulation in TG-treated cells
(Figure 3d).
HSPB1 enhances the proteasomal degradation of BIM.
To determine the mechanism of BIM downregulation by
HSPB1, we first assessed if it occurred at the transcriptional
level. Bim mRNA induction in response to TG treatment was
not affected by HSPB1 overexpression (Figure 4a), indicating
a post-transcriptional mechanism for BIM regulation by
HSPB1. We utilized a Bim 3′UTR reporter plasmid to
determine the effect of HSPB1 on regulation of BIM
expression at the post-transcriptional level. This luciferase
reporter construct spans 1038 nucleotides from bases +2123
to +3160 of the Bim 3′UTR that contains binding sites for
many microRNAs including members of the miR-106b-25
cluster, key microRNAs involved in the regulation of Bim
mRNA translation during ER stress.11 As expected, TG
Figure 5 HSPB1 forms complex with p-ERK1/2 and BIM. (a–c) EVand HSPB1 PC12 cells were treated with 0.25 μM TG for the indicated time. Lysates were immunoblotted
for HSPB1, p-BIM, BIM and ACTIN (n= 3) (a). Densitometric and statistical analysis of relative p-BIM expression in EV and HSPB1 cells was carried out and normalized relative
to total BIM (b). Cell lysates were immunoblotted for p-ERK1/2 and ERK1/2, p-JNK1/2 and JNK1/2 (n= 3) (c). (d) HSPB1 PC12 cells were treated with TG for 24 h followed by
immunoprecipitation with control IgG antibody or an antibody specific to HSPB1 or p-ERK1/2. Immune complexes were analyzed by immunoblotting for HSPB1, p-ERK1/2 and
BIM (n= 3). Data are representative or average± S.E.M. of indicated number of independent biological replicates. Significance was determined using two-way ANOVA followed
by Bonferroni’s post hoc analysis, with Po0.05 being considered significant and annotated by **Po0.001
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caused an increase in luciferase activity of the reporter
construct (Figure 4b).11 Overexpression of HSPB1 did not
affect the activity of the Bim 3′UTR construct (Figure 4b),
demonstrating that HSPB1 neither binds to the Bim 3′UTR
nor upregulates microRNAs belonging to miR-106b-25
cluster to inhibit Bim mRNA translation and/or stability.
Degradation of BIM by the proteasome is one of the well-
established mechanisms regulating BIM protein levels.32
Given that HSPB1 has been reported to mediate proteasomal
degradation of certain client proteins,33,34 we speculated that
HSPB1 might increase BIM protein turnover. To test this, we
monitored the half-life of BIM in the presence of mRNA
translation inhibitor, cycloheximide (CHX) (Figure 4c). The rate
of decay of basal levels of BIM was comparable in EV and
HSPB1 cells (Figures 4c and d). In EV-expressing cells treated
with TG, BIM’s half-life was prolonged from 6.5 h to 34.8 h
(Figures 4c and e). This supports a previous report showing
that BIM is stabilized during ER stress.7 Overexpression of
HSPB1 markedly accelerated BIM turnover upon ER stress,
and reduced BIM protein half-life to 3.2 h (Figures 4c and e).
Furthermore, HSPB1-mediated BIM decay was blocked by
proteasomal inhibition with MG132 (Figure 4f). These results
demonstrate that the HSPB1-dependent reduction in BIM
levels under conditions of ER stress is due to increased
proteasomal degradation.
HSPB1 enhances ERK1/2 phosphorylation and BIM
degradation and forms an HSPB1-ERK1/2- BIM complex.
Proteasomal degradation of BIM is mediated by ERK1/2-
dependent phosphorylation on Ser69 in human (Ser65 in
rodents).35 Immunoblotting revealed an increase in BIM
phosphorylation at Ser65 in EV and HSPB1 cells treated
with TG (Figure 5a). Owing to lower levels of total BIM in
HSPB1 cells, there was a significantly higher ratio of
phosphorylated BIM to total BIM in HSPB1 cells treated with
TG for 24 h compared with EV counterparts (Figure 5b).
Furthermore, the basal level of ERK1/2 phosphorylation was
significantly elevated upon overexpression of HSPB1
(Figure 5c). HSPB1-overexpressing cells maintained higher
levels of p-ERK1/2 compared with EV cells when exposed to
ER stress, even though phosphorylation of ERK1/2 transi-
ently declined at 12 and 24 h post-TG treatment and returned
to baseline levels after 48 h (Figure 5c). In neuronal cells, BIM
can also be phosphorylated by JNK on Ser65.14,32 Here we
show that ER stress induced JNK1/2 phosphorylation, which
was attenuated at 48 h in HSPB1 cells (Figure 5c).
Our data point to sustained ERK phosphorylation, accom-
panied by increased BIM degradation in HSPB1 cells. As
HSPB1 physically interactswithmany of its clients tomodulate
their activity or half-life,36–38 we hypothesized that HSPB1
facilitates BIM degradation by enhancing ERK1/2 and BIM
interaction. Co-immunoprecipitation demonstrated that both
p-ERK1/2 and BIM interact with HSPB1 independently of ER
stress in HSPB1 cells (Figure 5d) but not in EV cells, thus
confirming that HSPB1 is important for complex formation
(Figure 5d). A reduction in p-ERK1/2 pull-down was observed
in cells treated with TG (Figure 5d), which was probably due to
lower levels of p-ERK1/2 (compare input lanes with and
without TG treatment, Figure 5d). Reciprocal immunoprecipi-
tation of p-ERK1/2 in HSPB1-overexpressing cells demon-
strated co-immunoprecipitation of both BIM and HSPB1
(Figure 5d). The co-immunoprecipitation of HSPB1 with
p-ERK1/2 was much higher under ER stress conditions
(Figure 5d). This suggests that a proportion of p-ERK1/2
available in cells forms a complex with HSPB1 and BIM, but
that in cells treated with TG more of the available p-ERK1/2
interacts with HSPB1. These indicate that in HSPB1 cells
HSPB1 interacts with p-ERK1/2 and BIM.
HSPB1-mediated degradation of BIM is dependent on
MEK1/2-ERK1/2 signaling. To further investigate a role for
ERK1/2 in HSPB1-dependent BIM degradation we used a
Figure 6 HSPB1-mediated ER stress-induced apoptosis is dependent on the
MEK1/2-ERK1/2 pathway. (a) EV and HSPB1 cells were treated with 10 μM U0126
for 1 h following TG treatment for 24 and 48 h. Lysates were immunoblotted for BIM,
p-BIM, p-ERK1/2 and ERK1/2. ACTIN was used as a loading control. Data shown are
representative of three independent biological repeats. (b,c) EV and HSPB1 PC12
cells were pre-treated with 10 μM U0126 for 1 h before TG treatment for 48 h. The
percentage of apoptotic cells were determined by flow cytometry-based measure-
ment of Annexin V positivity (b), and DEVDase activity (c). Values are average±
S.E.M. of three independent biological repeats. Significance was determined using
Two-way ANOVA followed by Bonferroni’s post hoc analysis, with Po0.05 being
considered significant and annotated by *Po0.05
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pharmacological approach to inhibit MEK1/2, the upstream
kinase that activates ERK1/2.39 Treatment of cells with U0126
efficiently blocked ERK1/2 phosphorylation (Figure 6a).
There was notable accumulation of BIM and reduction in
BIM phosphorylation in HSPB1 cells undergoing ER stress in
which MEK1/2 was blocked (Figure 6a). These data indicate
that HSPB1-mediated BIM degradation is dependent on
MEK/ERK signaling.
We next investigated the role of ERK signaling in the
protection afforded by HSPB1 against ER stress-induced
apoptosis. Although HSPB1 cells were more resistant to ER
stress (Figures 6b and c), the presence of U0126 abrogated
HSPB1-mediated resistance to apoptosis, as determined by
Annexin V positivity and DEVDase activity (Figures 6b and c).
Collectively, these data demonstrate that HSPB1 sustains
phosphorylation of ERK1/2 that in turn phosphorylates BIM on
Ser65. Further, this signaling event is critical for proteasomal
degradation of BIM and for cell survival under conditions of ER
stress.
Discussion
Here, we report for the first time that HSPB1 can regulate the
stability of BIM protein by targeting it for proteasomal
degradation. This phosphorylation-dependent degradation of
BIM, is mediated by ERK1/2, which is supported by the
observation that pharmacological inhibition of ERK1/2 activa-
tion abrogated HSPB1-mediated BIM protein turnover and
sensitized cells to ER stress. Collectively, these data suggest
a novel mechanism by which HSPB1 can inhibit the intrinsic
apoptosis pathway, and demonstrates a novel way by which
BIM is regulated by HSPB1 during cell stress (Figure 7). This
work highlights the importance of HSPB1 in orchestrating
protection against stress-induced apoptosis, in particular ER
stress.
ER stress is known to engage the intrinsic apoptosis
pathway throughMOMP.26 The importance of BIM in activating
MOMP during ER stress has been reported by several groups,
including our own.4,7,40 However, the regulation of ER stress-
induced apoptosis by HSPs is not well understood. We have
previously shown that heat shock preconditioning, which leads
to induction of HSPA1 and HSPB1, can protect against ER
stress-induced apoptosis through regulation of BIM.17 The
regulation of BIM did not involve HSPA1. Previous studies
have highlighted protective effects of HSPB1 downstream of
the mitochondria through direct binding to cytochrome c and
caspase-3.41,42 Here we demonstrate that HSPB1 can also
act upstream of MOMP to avert caspase activation and
Figure 7 Schematic representation of HSPB1-mediated protection against ER stress-induced apoptosis. Induction of ER stress causes BIM-dependent activation of the
mitochondrial or intrinsic apoptosis pathway, which stimulates cytochrome c release from mitochondria that leads to apoptosome formation and consequently caspase activation
and apoptosis. Expression of HSPB1 causes formation of a protein complex comprising HSPB1, phospho-ERK1/2 and BIM. Phosphorylation of BIM by ERK1/2 targets it for
proteasomal degradation
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apoptosis induction in response to ER stress (Figure 1 and
Supplementary Figure 1). Other studies have also reported
the ability of HSPB1 to modulate apoptotic events upstream of
the mitochondria. HSPB1 can stabilize F-ACTIN, which
inhibits BID redistribution to the mitochondria and thus
cytochrome c release.23 We show here that targeting BIM for
proteasomal degradation represents an additional, novel
regulatory mechanism that contributes to HSPB1 inhibition
of the intrinsic apoptosis pathway upstream of MOMP.
Our findings underscore the complexity of apoptosis
regulation in response to stress. As we do not observe a
difference in caspase-3 cleavage upon HSPB1 depletion
despite higher levels of BIM (Figure 2f), we speculate that
HSPB1 is likely to act in concert with other cellular stress
response proteins to regulate apoptosis downstream of BIM.
For example, HSPA1, which is induced by ER stress
(Supplementary Figure 2c and e), can interfere with apoptosis
downstream of MOMP through inhibition of apoptosome
formation and caspase-9 activation.28,29 We have shown
previously that HSPA1 protects PC12 cells against ER stress-
induced apoptosis but does not downregulate BIM.17,27
The regulation of BIM expression is highly complex,
incorporating transcriptional induction, post-transcriptional
regulation by microRNAs, post-translational modifications
such as phosphorylation by ERK leading to BIM ubiquitination
and proteasomal degradation or phosphorylation by JNK
increasing BIM activity.43,44 HSPB1 has been shown to
regulate BIM through translation repression by binding to the
Bim 3′UTR during oxidative and excitotoxic stress in primary
neuronal cultures.6 In contrast to this, we did not observe an
effect of HSPB1 on Bim mRNA levels or on activity at the Bim
3′UTR. The reason for the different findings may be due to the
use of Bim 3′UTR construct that does not overlap with the
HSPB1-binding region identified in aforementioned study. We
cannot definitively exclude the possibility that HSPB1 acts
through an unidentified ER stress-regulated microRNA on a
region of the Bim 3′UTR that our reporter construct did not
include. Nonetheless, the data indicate multiple mechanisms
by which HSPB1 can tightly control BIM levels during cellular
stress.
To date, only a few client proteins that are targeted to the
proteasome in a HSPB1-dependent manner have been
identified, including IκBα,34 p27KIP1,45 GATA,46 CFTR47 and
AUF1.33,48 We now expand this list to include a protein that is
critically involved in stress-induced apoptosis. It remains
unanswered whether HSPB1-mediated targeting of BIM for
proteasomal degradation involves BIM ubiquitination. Activa-
tion of ERK1/2 signaling has been shown to prime BIM for
ubiquitination and subsequent proteasomal degradation.12
However, in our studies we did not detect any evidence of BIM
ubiquitination. It is interesting to note that ubiquitin-
independent proteasomal degradation of BIM driven by
ERK1/2 has recently been observed.49 Furthermore, HSPB1
can target other client proteins such as CFTR for proteasomal
degradation in a ubiquitin-independent manner.47 The protea-
somal degradation of BIM is dependent on its phosphorylation
by ERK1/2.32 We observed higher levels of BIM phosphoryla-
tion and of active ERK1/2 in HSPB1-overexpressing cells, and
furthermore, that HSPB1-mediated degradation of BIM is
dependent on active ERK1/2.
HSBP1, BIM and p-ERK1/2 interact to form a complex that
was detected in cells. It is possible that HSPB1 acts as a
scaffold protein bringing p-ERK1/2 and BIM together to
facilitate BIM phosphorylation and proteasomal degradation.
HSBP1, like other members of the sHSP family, are ATP-
independent, and function by holding misfolded proteins until
their proper folding can be catalyzed by ATP-dependent
chaperones such as HSPA1.50 As BIM is an intrinsically
disordered protein,49 it is possible that under conditions of
stress, HSPB1’s interaction with BIM is prolonged to allow
ERK-dependent phosphorylation, or that it holds BIM in a
conformation that favors its phosphorylation by ERK1/2.
Although our study focused on the role of HSPB1 in
promoting ERK-mediated BIM degradation, other degradation
pathways could also play a role. Emerging data suggest that
autophagy is part of the global ER stress response.51 In
human hepatocellular carcinoma cells hspb1 knockdown can
inhibit ER stress-induced autophagy.52 Thus, regulation of
autophagy might also contribute to the increased survival of
HSPB1 cells following ER stress. Whether such a mechanism
would also require downregulation of BIM would need further
investigation.
Mutations in the α-crystallin domain of HSPB1, including
R127W, S135F, R136W and T151I, have been linked to CMT
type 2 and dHMN.53 To date there have been no studies on the
response of cells expressing mutant HSPB1 to cellular stress.
Given the observed effect of HSPB1 on ERK1/2-mediated
degradation of BIM, we explored the response of cells
overexpressing mutant HSPB1 to ER stress. Here we show
that in contrast to WT HSPB1, the HSPB1 mutants failed to
protect against TG-induced apoptosis or to downregulate BIM.
In fact, all mutants tested increased BIM levels and sensitized
cells to ER stress compared with EV counterparts. HSPB1
R127W, S135F and R136W mutants exhibit increased
monomerization and increased chaperone activity compared
with the wild-type protein.30 In contrast, T151I mutant HSPB1
does not exhibit altered chaperone activity or increased
interaction with client proteins.30 This suggests that the
regulation of BIM by HSPB1 is independent of its chaperone
activity. An alternative explanation is that the interaction
between BIM and mutant HSPB1 is prolonged such that BIM
degradation is inhibited. However, this does not account for
the observation that the highest levels of BIM and of ER stress-
induced apoptosis are observed with the T151I mutant. There
is still a clear need to fully elucidate the physico-chemical and
functional properties of HSPB1 mutant proteins.
HSPB1 undergoes dynamic organization between small and
large oligomers ranging up to 1000 kDa.54 These dissociate
into dimers and tetramers under stress conditions.55,56 This
affects HSPB1’s chaperone function and ability to interact with
client proteins. Previous studies have shown that, at least in the
case of p27KIP1, small rather than large oligomers of HSPB1are
required to increase p27KIP1 degradation.45 As small HSPB1
oligomers are associated with cellular stress this suggests that
cellular stress promotes HSPB1 activity regarding proteasomal
degradation. We observed that HSPB1 overexpression sig-
nificantly reduced the half-life of BIM under ER stress but not
under normal conditions, suggesting that cellular stress might
be required for the effect of HSPB1 on BIM regulation. Indeed,
TG caused an increase in abundance of HSPB1 dimers and
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trimers (Supplementary Figure 3). Our data suggest that under
conditions of ER stress HSPB1 interacted more strongly with
p-ERK1/2 than under basal conditions. This could indicate
reorganization of HSPB1 quaternary structure during ER
stress. Understanding how p-ERK1/2 and BIM interact with
HSPB1 might provide insights to guide structure-based
therapeutic strategies to disrupt or enhance this complex. In
recent years, peptide aptamers (PAs) have been developed that
positively or negatively modulate the function and oligomeric
status of HSPB1.36 Such PAs will likely prove to be valuable
tools in the generation of chemical modulators of HSPB1, which
would have implications for the treatment of several diseases
including CMT and other motor neuropathies where HSPB1
mutations are involved in the disease. Activation of ER stress is
a salient feature of several neurodegenerative diseases.57 In
light of our finding that HSPB1 can inhibit ER stress-induced
apoptosis through increasing proteasomal degradation of BIM,
therapies aimed at increasing this activity may be of value in
neurodegenerative diseases in which ER stress has a
pathophysiological role.
Materials and Methods
Reagents. TG (T9033), TM (T7765), U0126 (U120), CHX (C7698) and MG132
(C2211) were purchased from Sigma-Aldrich (Saint Louis, Missouri, USA). Ac-Asp-
Glu-Val-Asp-a-(4-methyl-coumaryl-7-amide) (DEVD-MCA) was from the Peptide
Institute (Osaka, Japan, 3171-v).
Cell culture. Rat pheochromocytoma PC12 cells were obtained from the
European Collection of Authenticated Cell Cultures (Salisbury, UK). Cells were
routinely tested for mycoplasma contamination and only mycoplasma-free cells
were used. Cells were maintained in high-glucose Dulbecco’s Modified Eagle’s
medium from Sigma (D6429) supplemented with 10% heat inactivated horse serum,
5% fetal bovine serum, and 1% penicillin/streptomycin (Sigma) at 37 °C, 5% CO2 in
humidified incubator. Cells were seeded in poly-L-lysine-coated dishes at 4 × 104
cells/cm2 density 24 h prior to treatments. TG was used at a concentration of
0.25 μM and TM was used at 2 μg/ml unless otherwise stated.
Immunoblotting. Cells were lysed in RIPA buffer (50 mM Tris-HCl, pH 8.8,
150 mM NaCl, 0.5% (w/v) sodium deoxycholate, 0.1% (w/v) SDS, 1% (v/v) NP-40)
containing protease inhibitors (1 μM phenylmethylsulphonyl fluoride (PMSF), 1 μg/
ml Pepstatin, 10 μM Leupeptin, 2.5 μg/ml Aprotinin and 250 μM ALLN) and
phosphatase inhibitors (10 mM NaF, 1 mM Na3VO4). Proteins were separated by
SDS-PAGE, transferred to nitrocellulose membranes (GE Healthcare, Germany),
which were then incubated in 5% (w/v) non-fat milk dissolved in blocking solution
(phosphate-buffered saline containing 0.1% (v/v) Tween 20). Membranes were
probed with specific antibodies for: ACTIN (Sigma, A2066, 1 : 5000), p- BIM (CST,
Danvers, MA, USA, #4585, 1 : 1000), BIM (Stressgen, Farmingdale, NY, USA, ADI-
AAP-330, 1 : 2000), Caspase-3 (CST, #9662, 1 : 1000) Cleaved Caspase-3 (CST,
#9664, 1 : 1000), Caspase-9 (CST, #9508, 1 : 1000), p-ERK1/2 (CST, #9101,
1 : 1000), ERK1/2 (CST, #4696, 1:2000), p-JNK (CST, #9255, 1 : 1000), JNK (CST,
#9258, 1 : 2000), human HSPB1 (Stressgen, ADI-SPA-803, 1 : 1000), rat HSPB1
(Stressgen, ADI-SPA-801), HSPA1 (Stressgen, ADI-SPA-811), cytochrome c (BD
Biosciences, San Jose, CA, USA, #556433, 1 : 1000), CHOP (CST, #2895,
1 : 2000), p-eIF2α (CST, #3398, 1 : 1000), PERK (CST, #3192, 1 : 1000), HSPA5
(Stressgen, ADI-SPA-826, 1 : 1000). Phospho-specific antibodies were prepared in
5% (w/v) bovine serum albumin in PBS containing 0.1% (v/v) Tween 20. All
remaining antibodies were diluted in blocking solution. The horseradish peroxidase-
conjugated secondary antibodies were purchased from Jackson Immunoresearch
Europe Ltd (UK). The signal was visualized using enhanced chemiluminescence
reagent (Perkin Elmer, Waltham, MA, USA, NEL102001EA).
MTT assay. The mitochondrial metabolic function of cells was assayed by
monitoring the conversion of MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl
tetrazonium bromide) (Sigma, M5655) to purple formazan crystals in viable cells.
PC12 cells were plated into 96-well plates at 4 × 104 cells/cm2 in triplicate. After
carrying out an experiment, cells were incubated with 0.5 mg/ml of MTT for 3 h at
37 °C. To stop the reaction and solubilize the formazan crystals 1 volume of 20%
(w/v) SDS in 50% (v/v) dimethyl formamide was added and the absorbance was
measured at 550 nm by a Wallac 1420 plate-reader with a reference wavelength of
650 nm. Cell viability was expressed as percent of viable cells relative to the control.
Hematoxylin and eosin staining. Cells were scraped from culture flask
and 5 × 104 cells were spun onto glass slides (Shandon Cytospin 3), fixed in
methanol for 5 min at room temperature and stained in Harris hematoxylin solution
for 5 min. The staining was differentiated by a quick acid wash (25 mM HCl in 70%
(v/v) ethanol) and blued in Scott’s water (1% (w/v) MgSO4, 0.2% (w/v) NaHCO3 in
water). The cytosol was stained with Eosin Y for 10 s. Coverslips were placed on
slides using DPX mounting medium (Sigma). Cells were observed by light
microscopy (Olympus BX51 microscope).
Annexin V staining. Binding of Annexin V-FITC to externalized phosphati-
dylserine was used to determine extent of apoptosis in cultures. In brief, cells were
trypsinized, suspended in culture medium cells and left to recover for 15 min at
37 °C. Cells were collected by centrifugation at 300 g for 5 min. The supernatant
was removed and cells were re-suspended in 50 μl binding buffer (10 mM HEPES,
pH 7.5, 140 mM NaCl, 2.5 mM CaCl2) containing 1 μl of homemade Annexin
V-FITC and incubated in the dark on ice for 15 min. Prior to analysis 300 μl of
binding buffer was added. A total of 10000 cells per sample were collected using a
FACSCalibur flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA) and
analyzed by Cyflogic software.
Detection of DEVDase activity. Cells were harvested, pelleted by
centrifugation at 350 g, washed and re-suspended in 50 μl of ice-cold PBS. Each
lysate was divided equally into two wells of a microtiter plate and snap-frozen in dry
ice. Cell lysates and caspase substrate, Ac-DEVD-MCA, were combined in reaction
buffer (100 mM HEPES, pH 7.5, 10% (w/v) sucrose, 0.1% (w/v) CHAPS, 5 mM DTT,
and 0.0001% (v/v) NP-40, and 50 μM Ac-DEVD-MCA). The release of fluorescent
AMC was monitored at 1 min intervals over 1 h by Wallac Victor 1420 multilabel
counter (Perkin Elmer Life Sciences, Waltham, MA, USA) using excitation 355 nm,
and emission 460 nm wavelengths at 37 °C. Fluorescent units were converted to
nmol of AMC released using a standard curve generated with free AMC and
subsequently related to protein concentration.
Determination of cytochrome c release. Cells were trypsinized and
centrifuged at 150 g for 5 min at 4 °C. The cell pellet was washed once with PBS.
The cells were then lysed using 100 μl cell lysis and mitochondria intact buffer
containing (250 mM sucrose and 70 mM KCl in PBS, 0.1 mM PMSF, 1 mM
Dithiothreitol, 5 μg/ml Pepstatin, 10 μg/ml Leupeptin, 2 μg/ml Aprotinin and 25 μg/
ml Calpain inhibitor 1). Digitonin (10 μl of 20 mg/ml solution) was added to the
samples on ice for 5 min and then the cell suspension was centrifuged at 3000 g for
10 min at 4 °C. The supernatant was removed and stored as the cytosolic fraction,
at − 20 °C.
Changes in mitochondrial transmembrane potential. To measure
mitochondrial transmembrane potential (ΔΨm) cells were incubated with the
fluorescent probe 10 ng/ml tetramethylrhodamine ethyl ester (Molecular Probes,
Eugene, OR, USA, T669) added to the culture media for 30 min at room
temperature. A total of 10000 cells per sample were then analyzed on a
FACSCalibur flow cytometer (Becton Dickinson).
Densitometric analysis. Quantitative analysis of immunoblotting results was
performed using densitometric analysis with ImageJ software. The protein
expression was normalized to the loading control (ACTIN) and expressed relative
to untreated sample (otherwise indicated).
siRNA transfection. The sequences of siRNA (Dharmacon, Lafayette, CO,
USA) used in this study included following:
siGENOME SMART pool siRNA against Rat Bcl2l11 (Bim) (M-093533-01-0005):
D-093533-04: 5′-GUAAAUUCUGAGUGUGACA-3′
D-093533-03: 5′-ACGAGUUCAAUGAGACUUA-3′
D-093533-02: 5′-CGAGGAGGGCGUUUGCAAA-3′
D-093533-01: 5′-GGUUAUCUUACAACUGUUA-3′
and a non-targeting control (D-001206-13-00):
D-001206-13-01: 5′- AUGAACGUGAAUUGCUCAA-3′
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D-001206-13-02: 5′- UAAGGCUAUGAAGAGAUAC-3′
D-001206-13-03:5′-AUGUAUUGGCCUGUAUUAG-3′
D-001206-13-04: 5′- UAGCGACUAAACACAUCAA-3′
ON-TARGET plus SMART pool siRNA against Rat HspB1 (L-080155-02-0005):
J-080155-05: 5′-CGAGGCCCGUGCCCAAAUU-3′
J-080155-06: 5′-GGAACAGUCUGGAGCCAAG-3′
J-080155-07: 5′-CUACAUCUCUCGGUGCUUC-3′
J-080155-08: 5′-CCAAAGCAGUCACACAAUC-3′
and a non-targeting control (D-001810-10-20):
5′-UGGUUUACAUGUCGACUAA-3′
5′-UGGUUUACAUGUUGUGUGA-3′
5′-UGGUUUACAUGUUUUCUGA-3′
5′-UGGUUUACAUGUUUUCCUA-3′
siRNAs were re-suspended in RNase and DNase free Sigma water and stored at
− 80 °C. PC12 cells were transfected with 20 nM of Bim siRNA or 40 nM Hspb1
siRNA using Lipofectamine 2000 (Fermentas, Waltham, MA, USA). The
RNA-Lipofectamine complexes were incubated at room temperature for 20 min.
The complexes were added drop wise to the cells and incubated for 5 h at 37 °C.
Media was changed and 24 h later cells were used for experiments.
Plasmids. PC12 cells stably expressing wild-type HSPB1, R127W HSPB1,
S135F HSPB1, R136W HSPB1 and T151I HSPB1-overexpressing PC12 cells and
control EV cells were generated by transfection with empty pcDNA3.1(+) (Invitrogen,
Carlsbad, CA, USA) or pcDNA3.1 containing human HSPB1 cDNA sequence. The
following primers were used to generate the coding sequence for:
R127W HSPB1: forward 5′-GGCAAGCACGAGGAGTGGCAGGACGAGCAT-3′,
reverse 5′-ATGCTCGTCCTGCCACTCCTCGTGCTTGCC-3′
S135F HSPB1: forward 5′-GAGCATGGCTACATCTTCCGGTGCTTCACGCGG-3′,
reverse 5′-CCGCGTGAAGCACCGGAAGATGTAGCCATGCTC-3′
R136W HSPB1: forward 5′-CATGGCTACATCTCCTGGTGCTTCACGCGG-3′,
reverse 5′-CCGCGTGAAGCACCAGGAGATGTAGCCATG-3′
T151I HSPB1: forward 5′-GGTGTGGACCCCATCCAAGTTTCCTCCTCC-3′,
reverse 5′-GGAGGAGGAAACTTGGATGGGGTCCACACC-3′.
The PCR products containing the mutant open reading frames were then
recombined into a pcDNA vector, and the sequence was validated by sequencing.
Stable cell lines were produced by transient transfection and G418 selection as
previously described.17 Stable cells lines had been checked for similar expression
levels of HSPB1 (Figure 3a).
RNA extraction and real-time PCR. Total RNA was isolated using Trizol
(Invitrogen) according to the manufacturer's instructions. A total of 2 μg of RNA was
DNase treated followed by inactivation of DNase by EDTA (Invitrogen). Reverse
transcription was carried out with Oligo dT (Invitrogen) using 20 U Superscript II
Reverse Transcriptase (Invitrogen). cDNA was diluted 1:6 and mixed with 2 ×
TaqMan master mix and 20 × TaqMan Gene Expression Assays (Applied
Biosystems, Foster City, CA, USA). The cDNA was subjected to 40 cycles of
real-time PCR (95 °C for 10 s, 95 °C for 15 s and 60 °C for 60 s) using the forward
primer 5′-GTTGTAAGATAACCATTTGCGGG-3′ and reverse primer 5′-GAGGA
ACCTGAAGATCTGCG-3′ specific for Bcl2l11 (Bim). Gapdh (forward 5′-ACCACA
GTCCATGCCATC-3′ and reverse 5′-TCCACCACCTGTTGCTG-3′) was used as an
internal control.
Luciferase assay. The Bim 3′UTR construct was a gift from Dr. Klaus
Rajewsky, Harvard University, USA.58 The Bim 3′ UTR reporter plasmid containing
the putative binding site for members of miR17-92 cluster was cloned into the
psiCHECK2 vector (Promega, Madison, WI, USA), downstream the Renilla
luciferase gene. A psiCHECK2 vector also contains the Firefly reporter gene as the
intraplasmid transfection normalization reporter. In Bim 3′UTR reporter assays,
PC12 cells were transfected with 0.75 μg of psiCHECK2 vector or reporter plasmid
containing the Bim 3′UTR using Lipofectamine 2000 according to the
manufacturer’s instructions. Medium was changed 5 h after transfection and
treatments were performed 24 h later.
Cells were collected by spinning at 5000 g for 3 min using soft acceleration and
re-suspended in 50 μl of Dual-Glo Luciferase Reagent (Promega). Firefly luciferase
and Renilla luciferase activities were measured at 560 nm using 10 s luminescence
protocol on Wallac plate-reader and then normalized for Firefly luciferase activity.
Stop and Glo buffer was added between those two measurements.
Assessment of protein half-life. PC12 cells were treated with TG for 18 h
followed by treatment with 10 μM CHX for up to 3 h. Cells were harvested
at the indicated time and lysed to obtain protein extracts. Immunoblotting
analysis was performed as described previously. Densitometric analysis was
carried out and normalized to loading control (ACTIN). Data were fit to a mono-
exponential decay curve using Microsoft Excel where untreated or TG-treated
samples were set to 1.
Immunoprecipitation. Immunoprecipitation experiments were performed
using the Dynabeads Co-Immunoprecipitation Kit (Life Technologies, Lithuania,
14321D). In brief, on the day of the treatment, the beads were conjugated with
HSPB1 or p-ERK1/2 specific antibody or rabbit IgG (Jackson Immunoresearch, 011-
000-003) for 18 h at 37 °C. After the indicated time points cells were harvested and
lysed in NP-40 lysis buffer (150 mM NaCl, 1% (v/v) NP-40, 10% (v/v) glycerol,
10 mM Tris pH 8) with protease inhibitors (Roche Diagnostics GmbH, Germany,
11873580001) and phosphatase inhibitors (10 mM NaF, 1 mM Na3VO4) for 1 h at
4 °C. Lysates were centrifuged at 150 g for 5 min at 4 °C. Beads were added to the
lysate and incubated for 4 h at 4 °C with constant rotation. After the beads were
washed, samples were eluted and the 1 × Laemmli buffer was added. Samples
were boiled for 5 min at 95 °C, run on the SDS-PAGE gel and analyzed by
immunoblotting as described before.
Assessment of oligomeric status of HSPB1 following ER
stress. Cells were treated with 0.25 μM TG, TM for 12 h or heat shocked (as
described before)17 and left to recover for 2 h. Cells were harvested, pelleted by
centrifugation at 350 g, and washed in PBS. Cell pellets were lysed in lysis buffer
(25 mM HEPES, pH 7.4, 3.3% (v/v) glycerol, 1 mM EDTA, 1 mM DTT, 0.1 mM
PMSF) and snap-frozen with liquid nitrogen and thawed at 37 °C. Lysates were
chemically cross-linked by incubating with 1 volume of 0.1% (v/v) glutaraldehyde for
40 minutes at 30 oC. The cross-linking reaction was stopped by adding one volume
of stopping buffer (1 M Tris-HCl containing 10% (w/v) SDS and 10 mM EDTA).
Crossed-linked HSPB1 species were detected by immunoblotting as described
before.
Statistical analysis. Error bars represent means±S.E.M. of independent
biological replicates. Significance was determined using two-way ANOVA
followed by Bonferroni’s post hoc analysis, with Po0.05 being
considered significant and annotated by *Po0.05, **Po0.001, ***Po0.0001,
****Po0.00001.
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